Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with saralasin.

H C Mitchell, T K Keeton, W A Pettinger

    Kidney International. Supplement
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Certain medications like diuretics and vasodilators can affect blood pressure responses to saralasin, potentially causing drug interactions. Understanding these interactions is key for managing hypertension and predicting saralasin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Streamlining the neurosurgical ward.

    The American journal of nursing·2010
    Same author

    Functional efficiency in the physical medicine service.

    The Physiotherapy review·2010
    Same author

    Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1997
    Same author

    Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·1996
    Same author

    Autonomic ganglionitis with severe hypertension, migraine, and episodic but fatal hypotension.

    Neurology·1996
    Same author

    Sexual dimorphism of renal alpha2-adrenergic receptor regulation in Dahl rats.

    Hypertension research : official journal of the Japanese Society of Hypertension·1996
    Same journal

    Effect of kidney disease on glucose handling (including genetic defects).

    Kidney international. Supplement·2011
    Same journal

    Need for better diabetes treatment for improved renal outcome.

    Kidney international. Supplement·2011
    Same journal

    Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

    Kidney international. Supplement·2011
    Same journal

    SGLT2 inhibitors: molecular design and potential differences in effect.

    Kidney international. Supplement·2011
    Same journal

    Glucose handling by the kidney.

    Kidney international. Supplement·2011
    Same journal

    Bone: from a reservoir of minerals to a regulator of energy metabolism.

    Kidney international. Supplement·2011
    See all related articles

    Area of Science:

    • Pharmacology
    • Nephrology
    • Cardiovascular Medicine

    Background:

    • Saralasin is a drug used to assess the renin-angiotensin system's role in blood pressure regulation.
    • The blood pressure response to saralasin is influenced by intravascular volume and plasma renin activity (PRA).
    • Certain co-administered drugs can alter the efficacy and safety profile of saralasin therapy.

    Purpose of the Study:

    • To investigate the impact of diuretic and vasodilator drugs on the blood pressure response to saralasin.
    • To elucidate the mechanisms behind drug interactions involving saralasin.
    • To explore the potential for beneficial interactions, such as with beta-blockers, in managing saralasin-induced effects.

    Main Methods:

    • Analysis of existing literature and clinical data on saralasin administration in patients on diuretic or vasodilator therapy.

    Related Experiment Videos

  • Review of physiological mechanisms linking diuretics, vasodilators, renin-angiotensin system activity, and blood pressure.
  • Theoretical exploration of rebound hypertension following saralasin infusion.

    • Main Results:

    • Diuretic agents enhance saralasin-induced hypotension by depleting intravascular volume and increasing PRA.
    • Vasodilator agents can increase PRA and lead to angiotensin dependence of blood pressure, potentiating saralasin-induced hypotension.
    • Rebound hypertension after saralasin infusion may be linked to renin release disinhibition, suggesting a role for intrarenal mechanisms.
    • Propranolol may mitigate saralasin-induced renin release, indicating a potentially beneficial drug interaction.

    Conclusions:

    • Diuretic and vasodilator drugs significantly alter the blood pressure response to saralasin, necessitating careful consideration during co-administration.
    • Understanding these drug interactions is crucial for safe and effective use of saralasin in hypertension management.
    • Beta-blockers like propranolol may offer a protective effect against adverse reactions to saralasin, warranting further investigation.